Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 98–98 | Cite as

Copanlisib

Colitis: case report
Case report
  • 10 Downloads

Reference

  1. Dreyling M, et al. Long-term efficacy and safety from the copanlisib chronos-1 study in patients with relapsed or refractory indolent B-cell lymphoma. Blood 132 (Suppl. 1): 1595, Nov 2018. Available from: URL: http://doi.org/10.1182/blood-2018-99-114842 [abstract] - GermanyGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations